ASH released a statement from President Charles S. Abrams, MD, congratulating Congress on the passage of a short-term resolution to fund the NIH and other federal programs through December 9. ASH also applauds the inclusion of emergency supplemental funding for public health emergencies such as Zika virus. However, the Society remains concerned about the ongoing impact that limited funding extensions have on medical advancements that are dependent upon sustained and predictable support.
“Last year, Congress showed a strong bipartisan commitment to support biomedical research by providing a $2 billion increase for NIH in fiscal year (FY) 2016,” ASH representatives wrote in the news release. “Yet, if the nation is to continue to accelerate the development of life-changing cures, pioneering treatments, and innovative prevention strategies, it is essential for Congress to maintain this commitment.”
ASH recommended that Congress make passing full and final spending legislation for FY2017 – which includes $34.1 billion for NIH – a priority when it reconvenes in November. The Society is committed to working with lawmakers to pass a full FY2017 that ensures that lifesaving biomedical research continues, while promoting public health and safety.
ASH also encouraged Congress to recognize “the amazing progress we can make towards curing cancer by funding the Precision Medicine and National Cancer Moonshot initiatives. … Without congressional backing, ASH and our collaborative partners in the federal government and academia cannot continue our fight to conquer cancer.”
Source: ASH news release, September 29, 2016.